These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37401939)

  • 21. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
    Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
    Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C1QA, C1QB, and GZMB are novel prognostic biomarkers of skin cutaneous melanoma relating tumor microenvironment.
    Liang Z; Pan L; Shi J; Zhang L
    Sci Rep; 2022 Nov; 12(1):20460. PubMed ID: 36443341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and significance of programmed cell death-related gene expression signature in skin cutaneous melanoma.
    Wu X; Chen S; Ji Q; Chen H; Chen X
    Skin Res Technol; 2024 May; 30(5):e13739. PubMed ID: 38766879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
    Wang Y; Gong H; Cao Y
    Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma.
    Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
    Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and validation of TME-related signatures to predict prognosis and response to anti-tumor therapies in skin cutaneous melanoma.
    Lian W; Zheng X
    Funct Integr Genomics; 2023 May; 23(2):153. PubMed ID: 37160578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of anoikis-related subtypes and development of risk stratification system in skin cutaneous melanoma.
    Tian J; Cao ZJ; Zhang Y; Zhou JK; Yang L
    Heliyon; 2023 May; 9(5):e16153. PubMed ID: 37215879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new ferroptosis-related genetic mutation risk model predicts the prognosis of skin cutaneous melanoma.
    He J; Huang W; Li X; Wang J; Nie Y; Li G; Wang X; Cao H; Chen X; Wang X
    Front Genet; 2022; 13():988909. PubMed ID: 36685905
    [No Abstract]   [Full Text] [Related]  

  • 29. Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma.
    Hu B; Wei Q; Zhou C; Ju M; Wang L; Chen L; Li Z; Wei M; He M; Zhao L
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107162. PubMed ID: 33168410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel pyroptosis-related LncRNA signature predicts prognosis and indicates tumor immune microenvironment in skin cutaneous melanoma.
    Zhong J; Wang Z; Houssou Hounye A; Liu J; Zhang J; Qi M
    Life Sci; 2022 Oct; 307():120832. PubMed ID: 35940218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LSM2 is associated with a poor prognosis and promotes cell proliferation, migration, and invasion in skin cutaneous melanoma.
    Sun X; Zhang J; Hu J; Han Q; Ge Z
    BMC Med Genomics; 2023 Jun; 16(1):129. PubMed ID: 37312186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower Expression of GBP2 Associated With Less Immune Cell Infiltration and Poor Prognosis in Skin Cutaneous Melanoma (SKCM).
    Zhang S; Chen K; Zhao Z; Zhang X; Xu L; Liu T; Yu S
    J Immunother; 2022 Jul-Aug 01; 45(6):274-283. PubMed ID: 35543550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
    Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
    Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
    Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of the paired box gene 3 inhibits the progression of skin cutaneous melanoma by inhibiting c-MET tyrosine kinase : PAX3 downregulation inhibits melanoma progression.
    Zhang K; Yu C; Tian R; Zhang W; Tang S; Wang G
    Mol Biol Rep; 2022 Oct; 49(10):9137-9145. PubMed ID: 36057879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic Multiomic Analysis of
    Kang JY; Yang J; Lee H; Park S; Gil M; Kim KE
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated analysis to reveal potential therapeutic targets and prognostic biomarkers of skin cutaneous melanoma.
    Zhou X; Rong R; Xiong S; Song W; Ji D; Xia X
    Front Immunol; 2022; 13():914108. PubMed ID: 36032150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of sterile a-motif domain-containing 9-like as a potential biomarker in patients with cutaneous melanoma.
    Ye J; Tang H; Xie C; Han W; Shen G; Qian Y; Xu J
    PeerJ; 2023; 11():e15634. PubMed ID: 37426410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic and immune-related value of STK17B in skin cutaneous melanoma.
    Shi X; Zhou Q; Huang B; Xia S; Jiang Y; Fang S; Lin J
    PLoS One; 2022; 17(2):e0263311. PubMed ID: 35171924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mining database for the clinical significance and prognostic value of CBX family in skin cutaneous melanoma.
    Li D; Liu Y; Hao S; Chen B; Li A
    J Clin Lab Anal; 2020 Dec; 34(12):e23537. PubMed ID: 32860274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.